Since p53 has been implicated in cancer metabolism reprogramming and several metabolic disorders including T2D and obesity, we studied the mutational landscape of the protein in a group of 53 patients of our series in order to explore any associations with BMI, T2D, and HT. This evidence concerns the gene TP53 and obesity disorder.